Amarin Corp Plc (AMRN)

[ralphey]

Yea Agreed ...as a doctor I too hope for success , however, AMRN really screwed up by not having a statin intolerant branch - do they have any realization how serious this oversight is ?


In statin naive patients there may have been much better potential for success than in patients already taking - and success here would have opened the door for direct competition against statins

THIS IS A MAJOR FLAW AND MAY COST INVESTORS HUGELY

it would have been so easy - this is incompetence and investors have a right to be upset over this study design for having missed this very basic point.